LIVER TRANSPLANT RECIPIENTS
Clinical trials for LIVER TRANSPLANT RECIPIENTS explained in plain language.
Never miss a new study
Get alerted when new LIVER TRANSPLANT RECIPIENTS trials appear
Sign up with your email to follow new studies for LIVER TRANSPLANT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Transplant patients get stronger COVID protection by temporarily lowering immune drugs
Disease control CompletedThis study looked at 48 kidney and liver transplant recipients who had a weak antibody response after their initial COVID-19 vaccines. Researchers gave everyone an extra mRNA booster shot and randomly assigned some to temporarily reduce their immunosuppressive medications. The go…
Matched conditions: LIVER TRANSPLANT RECIPIENTS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Liver transplant study seeks rejection warning signs
Knowledge-focused CompletedThis study looked at 221 liver transplant recipients to see if a lab test could predict which patients are more likely to reject their new liver. Researchers analyzed gene expression patterns to find signatures of rejection or tolerance. The goal was to improve monitoring and car…
Matched conditions: LIVER TRANSPLANT RECIPIENTS
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC